Kras Altered Advanced Or Metastatic Solid Tumors clinical trials

Explore recruiting kras altered advanced or metastatic solid tumors clinical trials.

Recruiting kras altered advanced or metastatic solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kras Altered Advanced Or Metastatic Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AMG 410 Alone and in Combination with other agents in Participants with KRAS Altered Advanced or Metastatic Solid Tumors

France, Netherlands, Germany, Denmark, Spain, Italy +1 more

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Kras Altered Advanced Or Metastatic Solid Tumors trials by city

Kras Altered Advanced Or Metastatic Solid Tumors in Toronto Kras Altered Advanced Or Metastatic Solid Tumors in Vancouver Kras Altered Advanced Or Metastatic Solid Tumors in Montreal Kras Altered Advanced Or Metastatic Solid Tumors in Calgary Kras Altered Advanced Or Metastatic Solid Tumors in Edmonton Kras Altered Advanced Or Metastatic Solid Tumors in Ottawa Kras Altered Advanced Or Metastatic Solid Tumors in Winnipeg Kras Altered Advanced Or Metastatic Solid Tumors in Quebec City Kras Altered Advanced Or Metastatic Solid Tumors in Hamilton Kras Altered Advanced Or Metastatic Solid Tumors in Kitchener Kras Altered Advanced Or Metastatic Solid Tumors in London Kras Altered Advanced Or Metastatic Solid Tumors in Halifax Kras Altered Advanced Or Metastatic Solid Tumors in New York Kras Altered Advanced Or Metastatic Solid Tumors in Los Angeles Kras Altered Advanced Or Metastatic Solid Tumors in Chicago Kras Altered Advanced Or Metastatic Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease